Vancouver’s Curatio has raised a Series A round led by Vancouver’s Rhino Ventures with participation from Conexus Venture Capital Fund. The amount of funding has not been disclosed.

Curatio is a digital health company that has developed the world’s first social health prescription to tackle loneliness and isolation. Used in over 85 countries and available in 5 languages, Curatio provides health organizations with a way to create their own private social networks for patients using a privacy and regulatory compliant software platform.

With this new funding, Curatio will continue its global expansion and grow their team to help meet substantial pent up demand from the healthcare sector.

“Right now, the entire world is experiencing the type of isolation that millions of patients face every day. We know that when patients and their families are provided with peer support and daily disease management tools they have improved health outcomes, higher adherence, and better quality of life. What we have built at Curatio is a way to deliver that type of support at scale on a platform that is designed for the highest level of privacy and regulatory compliance required by healthcare”, said Lynda Brown-Ganzert, Curatio CEO & Co-Founder.

“With COVID-19, Curatio’s solution is needed to keep patients healthy at home and help healthcare organizations rapidly transition to virtual delivery.”

Founded in 2013 by Brown-Ganzert and Alireza Davoodi, Curatio licenses their platform to hospitals, insurers, research organizations, patient advocacy groups, non-profits, and pharmaceutical manufacturers around the world that are desperately in need of virtual healthcare solutions, especially during COVID-19.

Used by some of the largest healthcare companies in the world, Curatio has won numerous awards and widespread industry recognition for the way it combines social support and disease management with AI, machine learning, and virtual patient monitoring.